Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PROTEIN DESIGN LABS INC/DE | 421,680 | reported | 09 Apr 2008 | tx 50+476,000−511,000 |
| INSITE VISION INC | 200,000 | reported | 10 Dec 2007 | tx 4+75,000 |
| DURECT CORP | 55,000 | reported | 17 Jun 2020 | tx 125+789,792 |
| Vistagen Therapeutics, Inc. | 17,600 | reported | 09 Sept 2025 | tx 79+1,745,355−473,784 |
| QUESTCOR PHARMACEUTICALS INC | 7,500 | reported | 01 Jan 2006 | tx 8+90,000 |
| SCICLONE PHARMACEUTICALS INC | 0 | reported | 13 Oct 2017 | tx 41+525,000−525,000 |
| INCYTE CORP | 0 | reported | 30 Mar 2004 | tx 2+20,000−20,000 |
| FIRST HORIZON PHARMACEUTICAL CORP | 0 | reported | 23 May 2008 | tx 14+52,250−30,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Sept 2025 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 17,600 | 0.00 USD | deriv |
| 06 Sept 2024 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 14,100 | 0.00 USD | deriv |
| 04 Mar 2024 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 01 Mar 2022 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 19 Mar 2021 | EXERCISE | Vistagen Therapeutics, Inc. | 2,500 | 1.50 USD | |
| 19 Mar 2021 | EXERCISE | Vistagen Therapeutics, Inc. | 2,500 | 0.00 USD | deriv |
| 30 Dec 2020 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 21 Aug 2020 | PURCHASE | Vistagen Therapeutics, Inc. | 30,000 | 0.69 USD | first after silence |
| 17 Jun 2020 | GRANT_AWARD | DURECT CORP | 55,000 | 0.00 USD | deriv |
| 23 Apr 2020 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 21 Oct 2019 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 19 Jun 2019 | GRANT_AWARD | DURECT CORP | 55,000 | 0.00 USD | deriv |
| 10 Jun 2019 | PURCHASE | DURECT CORP | 2,900 | 0.56 USD | |
| 10 Jun 2019 | PURCHASE | DURECT CORP | 74 | 0.56 USD | |
| 10 Jun 2019 | PURCHASE | DURECT CORP | 626 | 0.56 USD | |
| 10 Jun 2019 | PURCHASE | DURECT CORP | 3,449 | 0.56 USD | |
| 10 Jun 2019 | PURCHASE | DURECT CORP | 1,400 | 0.55 USD | |
| 10 Jun 2019 | PURCHASE | DURECT CORP | 400 | 0.55 USD | |
| 10 Jun 2019 | PURCHASE | DURECT CORP | 1,800 | 0.55 USD | |
| 10 Jun 2019 | PURCHASE | DURECT CORP | 300 | 0.55 USD | |
| 10 Jun 2019 | PURCHASE | DURECT CORP | 500 | 0.55 USD | |
| 10 Jun 2019 | PURCHASE | DURECT CORP | 1,400 | 0.55 USD | |
| 10 Jun 2019 | PURCHASE | DURECT CORP | 300 | 0.55 USD | |
| 10 Jun 2019 | PURCHASE | DURECT CORP | 1,751 | 0.55 USD | |
| 10 Jun 2019 | PURCHASE | DURECT CORP | 100 | 0.55 USD |
3 purchases reported after at least 12 months of silence — most recent on 21 Aug 2020.